| Bioactivity | Azithromycin hydrate is a macrolide antibiotic useful for the treatment of a number of bacterial infections. |
| Invitro | Azithromycin (2 μM) augments rhinovirus-induced IFNβ expression in primary bronchial epithelial cells from asthmatics, which is associated with over-expression of RIG-I like receptors and repression of viral replication. Knockdown of MDA5, but not knockdown of RIG-I, diminishes azithromycin (2 μM)-enhanced viral-induced IFNβ expression in asthmatic primary bronchial epithelial cells[1]. Azithromycin specifically reduces MMP-9 mRNA and protein levels without affecting NF-κB in endotoxin-challenged monocytic THP-1 cells[2]. |
| Name | Azithromycin hydrate |
| CAS | 117772-70-0 |
| Formula | C38H76N2O14 |
| Molar Mass | 785.02 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Azithromycin hydrate
CAS: 117772-70-0 F: C38H76N2O14 W: 785.02
Azithromycin hydrate is a macrolide antibiotic useful for the treatment of a number of bacterial infections.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.